Synonym
PX20606; PX-20606; PX 20606; PX-102; PX 102; PX102. Px-104; Px104; Px 104;
IUPAC/Chemical Name
4-((1R,2R)-2-(2-chloro-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)phenyl)cyclopropyl)benzoic acid
InChi Key
XBUXXJUEBFDQHD-NHCUHLMSSA-N
InChi Code
InChI=1S/C29H22Cl3NO4/c30-23-2-1-3-24(31)26(23)27-22(28(37-33-27)16-6-7-16)14-36-18-10-11-19(25(32)12-18)21-13-20(21)15-4-8-17(9-5-15)29(34)35/h1-5,8-12,16,20-21H,6-7,13-14H2,(H,34,35)/t20-,21-/m1/s1
SMILES Code
O=C(O)C1=CC=C([C@@H]2[C@@H](C3=CC=C(OCC4=C(C5CC5)ON=C4C6=C(Cl)C=CC=C6Cl)C=C3Cl)C2)C=C1
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Related CAS#
1268245-19-7 ( PX20606 free acid);
1268245-21-1 ( PX20606 tris salt).
1268244-85-4 ( PX20606 trans isomer);
1268244-86-5 ( PX20606 trans isomer, tris salt).
Preparing Stock Solutions
The following data is based on the
product
molecular weight
554.85
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Deuschle U, Birkel M, Hambruch E, Hornberger M, Kinzel O, Perović-Ottstadt S,
Schulz A, Hahn U, Burnet M, Kremoser C. The nuclear bile acid receptor FXR
controls the liver derived tumor suppressor histidine-rich glycoprotein. Int J
Cancer. 2015 Jun 1;136(11):2693-704. doi: 10.1002/ijc.29312. Epub 2014 Nov 13.
PubMed PMID: 25363753.
2: Hambruch E, Miyazaki-Anzai S, Hahn U, Matysik S, Boettcher A, Perović-Ottstadt
S, Schlüter T, Kinzel O, Krol HD, Deuschle U, Burnet M, Levi M, Schmitz G,
Miyazaki M, Kremoser C. Synthetic farnesoid X receptor agonists induce
high-density lipoprotein-mediated transhepatic cholesterol efflux in mice and
monkeys and prevent atherosclerosis in cholesteryl ester transfer protein
transgenic low-density lipoprotein receptor (-/-) mice. J Pharmacol Exp Ther.
2012 Dec;343(3):556-67. doi: 10.1124/jpet.112.196519. Epub 2012 Aug 23. PubMed
PMID: 22918042.